These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. A systemic lupus erythematosus patient presenting as type B insulin resistance complicated with cryoglobulinemia. Huang Q; Yan Y; Zhao H; Zuo L Lupus; 2017 Jan; 26(1):95-97. PubMed ID: 27416845 [TBL] [Abstract][Full Text] [Related]
64. Cryoprecipitation. In vitro studies on fibronectin as an independent cryoprecipitagogue. Ferraccioli G Ric Clin Lab; 1986; 16(2):315-20. PubMed ID: 2431453 [TBL] [Abstract][Full Text] [Related]
65. [Selective lymphapheresis (a method for the selective elimination of cellular elements and fibronectin complexes from the lymph) in systemic scleroderma]. Vasil'ev SA; Archvadze VG; Alekseev GI; Baranovich VIu; Efremov EE; Ermolin GA; Zherdeva LV; Guseva NG; Baranauskaĭte AA Ter Arkh; 1992; 64(7):93-7. PubMed ID: 1440379 [No Abstract] [Full Text] [Related]
66. Increased plasma fibronectin in patients with systemic lupus erythematosus. Nishinarita S; Yamamoto M; Takizawa T; Hayakawa J; Karasaki M; Sawada S Clin Rheumatol; 1990 Jun; 9(2):214-9. PubMed ID: 2202543 [TBL] [Abstract][Full Text] [Related]
67. [Cryoglobulins and their role in renal pathologies]. Bridoux F; Provôt F; Abou Ayache R; Goujon JM; Touchard G Presse Med; 2003 Mar; 32(12):561-2. PubMed ID: 12714924 [No Abstract] [Full Text] [Related]
68. Plasma fibronectin is a component of cryoglobulins from patients with connective tissue and other diseases. Anderson B; Rucker M; Entwistle R; Schmid FR; Wood GW Ann Rheum Dis; 1981 Feb; 40(1):50-4. PubMed ID: 6781419 [TBL] [Abstract][Full Text] [Related]
70. Serum C1q concentrations in rheumatic disorders. Early normalization during treatment of immunologically-mediated vasculitis. Persellin RH; Cheng CT Am J Clin Pathol; 1981 Oct; 76(4):462-6. PubMed ID: 6794352 [TBL] [Abstract][Full Text] [Related]
71. [The content of fibronectin in the blood of patients with psoriasis]. Vasil'eva NIu; Nazimova SV; Tatarinov IuS Lab Delo; 1991; (3):27-8. PubMed ID: 1710713 [TBL] [Abstract][Full Text] [Related]
72. Cryoglobulins and infectious diseases. Galli M; Invernizzi F; Chemotti M; Monti G; Gasparro MG; Caredda F; Negri C; Moroni M Ric Clin Lab; 1986; 16(2):301-13. PubMed ID: 3097790 [TBL] [Abstract][Full Text] [Related]
73. [Reaction of peripheral blood leukocyte migration inhibition in the presence of DNA in patients with systemic lupus erythematosus]. Cherniak VI; Savel'ev AI; Mikhailova VS Klin Med (Mosk); 1975 Nov; 53(11):97-102. PubMed ID: 1223524 [No Abstract] [Full Text] [Related]
74. Structural and functional characterization of plasma fibronectin in patients with essential mixed cryoglobulinaemia. Toschi V; Fiorini GF; Motta A; Castelli C; Gagliano MG; Gibelli A Eur J Clin Chem Clin Biochem; 1992 Aug; 30(8):473-9. PubMed ID: 1445961 [TBL] [Abstract][Full Text] [Related]
75. [The binding capacity of serum immunoglobulins with amino acids in systemic lupus erythematosus]. Zamulko AA; Fedorich VN; Amosova EN Vrach Delo; 1991 Jul; (7):47-9. PubMed ID: 1771834 [TBL] [Abstract][Full Text] [Related]
76. Presence of fibronectin in cold precipitates of patients with cryoimmunoglobulinemia. Levo Y Int Arch Allergy Appl Immunol; 1982; 68(2):179-81. PubMed ID: 6281199 [TBL] [Abstract][Full Text] [Related]
77. [Lupus erythematodes visceralis and age (part II) (author's transl)]. Apostoloff E; Schmidt UJ; Hofer E; Meffert H Z Alternsforsch; 1977; 32(2):147-56. PubMed ID: 906565 [TBL] [Abstract][Full Text] [Related]
78. Long term effects of cryoapheresis and cytostatic treatment in essential mixed cryoglobulinemia. L'Abbate A; Maggiore Q; Caccamo A; Misefari V; Bartolomeo F; Delfino D; Cutrupi S; Pagnotta G Int J Artif Organs; 1985 Jul; 8 Suppl 2():19-22. PubMed ID: 4055106 [TBL] [Abstract][Full Text] [Related]